Medically Approved App Can Now Treat Depression

The U.S. FDA’s approval of digital therapeutic apps to treat depression marks an innovative step forward in mental health care. The app, called Rejoyn, is cleared as a supplement to currently approved therapies and works by using specifically designed tasks on a smartphone app to rewire neural signals. Joining the list of apps, such as reSET for substance use disorder and EndeavorRx for ADHD in children, which represents a growing field of digital therapeutics designed to provide evidence-based treatments through smartphones, tablets, and other digital platforms. Approved digital therapies for depression utilize clinically tested techniques such as cognitive-behavioral therapy (CBT), mindfulness, and mood tracking to support users in managing symptoms. These apps also make mental health care more accessible, especially for individuals who may face barriers to traditional therapy, such as location, cost, or stigma.

One of the key benefits of these apps is the ability to track progress and personalize treatment. By collecting data on mood patterns, sleep, and activity levels, the apps can offer personalized insights and reminders that help individuals better understand their mental health and make gradual adjustments. Some even feature interactive sessions guided by virtual coaches or chatbots, allowing users to engage with therapeutic techniques and skills at any time. This approach has been found effective for people with mild to moderate depression, who can benefit from consistent, daily engagement without needing regular in-person therapy sessions.

Here’s an image of a person symbolizing recovery from depression, sitting in a bright, peaceful room with a calm and hopeful expression.

Although these apps aren’t substitutes for medical professionals, their approval reflects a recognition of their potential as complementary tools in treating mental health disorders. For more severe cases, these apps can be used alongside medication and counseling, providing a holistic approach to mental health care. With continued advancements and monitoring, the development of U.S.-sanctioned mental health apps could expand further, addressing a range of conditions and making mental health care more accessible to people worldwide.